{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T09:47:55Z","timestamp":1785232075348,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Research Centre Egypt"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Lysosomal storage diseases (LSDs) is a large group of genetically heterogeneous inherited metabolic disorders that affect the functions of the lysosomes in various human tissues. Mucopolysaccharidosis type IIIA (MPSIIIA), Sanflippo syndrome A, is a rare autosomal recessive LSD caused by biallelic variants in the <jats:italic>SGSH<\/jats:italic> gene, codes for the lysosomal enzyme heparan-N-sulphatase. This study aimed to find out the SGSH mutational spectrum, clinical and biochemical characteristics in a cohort of MPS IIIA Egyptian patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Ten patients derived from 9 unrelated families, clinically and biochemically diagnosed having MPS IIIA secondary to heparan sulphatase deficiency, were enrolled. Patients, variably, displayed early-onset and progressive neurological and mental deterioration, aggressive and hyperactive behaviors, sleep disturbances and visceromegaly. Sanger sequencing of the <jats:italic>SGSH<\/jats:italic> coding and exon-intron boundaries revealed four homozygous disease-causing variants in all the patients (100%), three previously reported (p.Y224*, p.R377C, and p.V361Sfs*52), and a novel one (c.948delA; p.D317Tfs*96). The p.Y224* in exon 6 was the most recurrent variant (5\/10, 50%), followed by the missense R377C in exon 8 (3\/10; 30%), while the two frameshift truncating variants, each appeared in only one patient; presenting 10% of the disease causing variants.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The pattern of variants recurrence in unrelated Egyptian patients highlights exons 6 and 8 as hot spots for first variant screening. The molecular findings of this study expand the <jats:italic>SGSH v<\/jats:italic>ariant spectrum and underline specific exons for first screening of MPS IIIA patients, which would largely help the early diagnosis and genetic counselling. To the best of our knowledge, the present study is the first delineating the <jats:italic>SGSH<\/jats:italic> variant profile in Egyptian Sanflippo A patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03971-2","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T12:12:07Z","timestamp":1756123927000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical, biochemical, and molecular characteristics of Sanfilippo a syndrome (MPS IIIA) in a cohort of Egyptian patients"],"prefix":"10.1186","volume":"20","author":[{"given":"Ekram","family":"Fateen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soha S.","family":"Nosier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahla N. Abdel","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira M.","family":"Radwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8860-0980","authenticated-orcid":false,"given":"Eman E.A.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"issue":"2","key":"3971_CR1","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s10545-008-0838-5","volume":"31","author":"MJ Valstar","year":"2008","unstructured":"Valstar MJ, Ruijter GJG, van Diggelen OP, Poorthuis BJ, Wijburg FA. Sanfilippo syndrome: a mini-review. J Inherit Metab Dis. 2008;31(2):240\u201352.","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"3971_CR2","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/ped.12636","volume":"57","author":"F Andrade","year":"2015","unstructured":"Andrade F, Ald\u00e1miz-Echevarr\u00eda L, Llarena M, Couce ML. Sanfilippo syndrome: overall review. Pediatr Int. 2015;57(3):331\u20138.","journal-title":"Pediatr Int"},{"key":"3971_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-019-1232-0","volume":"14","author":"SC Nijmeijer","year":"2019","unstructured":"Nijmeijer SC, van den Born LI, Kievit AJ, Stepien KM, Langendonk J, Marchal JP, et al. The attenuated end of the phenotypic spectrum in MPS III: from late-onset stable cognitive impairment to a non-neuronopathic phenotype. Orphanet J Rare Dis. 2019;14:1\u201310.","journal-title":"Orphanet J Rare Dis"},{"issue":"7","key":"3971_CR4","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1002\/ajmg.a.34053","volume":"155","author":"N Muschol","year":"2011","unstructured":"Muschol N, Pohl S, Meyer A, Gal A, Ullrich K, Braulke T. Residual activity and proteasomal degradation of p. Ser298Pro sulfamidase identified in patients with a mild clinical phenotype of Sanfilippo A syndrome. Am J Med Genet A. 2011;155(7):1634\u20139.","journal-title":"Am J Med Genet A"},{"issue":"1","key":"3971_CR5","doi-asserted-by":"publisher","first-page":"46576","DOI":"10.1038\/srep46576","volume":"7","author":"CA Dwyer","year":"2017","unstructured":"Dwyer CA, Scudder SL, Lin Y, Dozier LE, Phan D, Allen NJ, et al. Neurodevelopmental changes in excitatory synaptic structure and function in the cerebral cortex of Sanfilippo syndrome IIIA mice. Sci Rep. 2017;7(1):46576.","journal-title":"Sci Rep"},{"issue":"2","key":"3971_CR6","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3390\/jcm9020396","volume":"9","author":"GM Viana","year":"2020","unstructured":"Viana GM, Priestman DA, Platt FM, Khan S, Tomatsu S, Pshezhetsky AV. Brain pathology in mucopolysaccharidoses (MPS) patients with neurological forms. J Clin Med. 2020;9(2):396.","journal-title":"J Clin Med"},{"issue":"4","key":"3971_CR7","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/ng1295-465","volume":"11","author":"HS Scott","year":"1995","unstructured":"Scott HS, Blanch L, Guo XH, Freeman C, Orsborn A, Baker E, et al. Cloning of the sulphamidase gene and identification of mutations in Sanfilippo A syndrome. Nat Genet. 1995;11(4):465\u20137.","journal-title":"Nat Genet"},{"issue":"4","key":"3971_CR8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/dnares\/3.4.269","volume":"3","author":"LE Karageorgos","year":"1996","unstructured":"Karageorgos LE, Guo XH, Blanch L, Weber B, Anson DS, Scott HS, et al. Structure and sequence of the human sulphamidase gene. DNA Res. 1996;3(4):269\u201371.","journal-title":"DNA Res"},{"issue":"1","key":"3971_CR9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0009-8981(77)90466-1","volume":"79","author":"P Whiteman","year":"1977","unstructured":"Whiteman P, Henderson H. A method for the determination of amniotic-fluid glycosaminoglycans and its application to the prenatal diagnosis of hurler and Sanfilippo diseases. Clin Chim Acta. 1977;79(1):99\u2013105.","journal-title":"Clin Chim Acta"},{"issue":"3","key":"3971_CR10","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1399-0004.1985.tb00217.x","volume":"27","author":"J Marsh","year":"1985","unstructured":"Marsh J, Fensom A. 4-methylumbelliferyl \u03b1\u2010N\u2010acetylglucosaminidase activity for diagnosis of Sanfilippo B disease. Clin Genet. 1985;27(3):258\u201362.","journal-title":"Clin Genet"},{"issue":"3","key":"3971_CR11","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","volume":"16","author":"SA Miller","year":"1988","unstructured":"Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215.","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"3971_CR12","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1136\/jmg.37.9.704","volume":"37","author":"CE Beesley","year":"2000","unstructured":"Beesley CE, Young EP, Vellodi A, Winchester BG. Mutational analysis of Sanfilippo syndrome type A (MPS IIIA): identification of 13 novel mutations. J Med Genet. 2000;37(9):704\u20137.","journal-title":"J Med Genet"},{"issue":"5","key":"3971_CR13","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17(5):405\u201323.","journal-title":"Genet Med"},{"issue":"5","key":"3971_CR14","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/humu.21438","volume":"32","author":"IF Fokkema","year":"2011","unstructured":"Fokkema IF, Taschner PE, Schaafsma GC, Celli J, Laros JF, den Dunnen JT. LOVD v. 2.0: the next generation in gene variant databases. Hum Mutat. 2011;32(5):557\u201363.","journal-title":"Hum Mutat"},{"issue":"6","key":"3971_CR15","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/humu.10212","volume":"21","author":"PD Stenson","year":"2003","unstructured":"Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, Thomas NS, et al. Human gene mutation database (HGMD\u00ae): 2003 update. Hum Mutat. 2003;21(6):577\u201381.","journal-title":"Hum Mutat"},{"issue":"1","key":"3971_CR16","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/nar\/29.1.308","volume":"29","author":"ST Sherry","year":"2001","unstructured":"Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, et al. DbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 2001;29(1):308\u201311.","journal-title":"Nucleic Acids Res"},{"issue":"7571","key":"3971_CR17","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"1000 Genomes Project Consortium","year":"2015","unstructured":"1000 Genomes Project Consortium. A global reference for human genetic variation. Nature. 2015;526(7571):68.","journal-title":"Nature"},{"key":"3971_CR18","doi-asserted-by":"crossref","unstructured":"Chen S, Francioli LC, Goodrich JK, Collins RL, Kanai M, Wang Q et al. A genome-wide mutational constraint map quantified from variation in 76,156 human genomes. BioRxiv. 2022;2022\u201303.","DOI":"10.1101\/2022.03.20.485034"},{"issue":"11","key":"3971_CR19","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1093\/bioinformatics\/bty897","volume":"35","author":"C Kopanos","year":"2019","unstructured":"Kopanos C, Tsiolkas V, Kouris A, Chapple CE, Aguilera MA, Meyer R, et al. VarSome: the human genomic variant search engine. Bioinformatics. 2019;35(11):1978.","journal-title":"Bioinformatics"},{"key":"3971_CR20","first-page":"100811","volume":"29","author":"RJ Lehmann","year":"2021","unstructured":"Lehmann RJ, Jolly LA, Johnson BV, Lord MS, Kim HN, Saville JT, et al. Impaired neural differentiation of MPS IIIA patient induced pluripotent stem cell-derived neural progenitor cells. Mol Genet Metab Rep. 2021;29:100811.","journal-title":"Mol Genet Metab Rep"},{"issue":"6","key":"3971_CR21","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1002\/ana.22092","volume":"68","author":"MJ Valstar","year":"2010","unstructured":"Valstar MJ, Neijs S, Bruggenwirth HT, Olmer R, Ruijter GJ, Wevers RA, et al. Mucopolysaccharidosis type IIIA: clinical spectrum and genotype-phenotype correlations. Ann Neurol. 2010;68(6):876\u201387.","journal-title":"Ann Neurol"},{"issue":"1","key":"3971_CR22","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s43141-023-00586-7","volume":"21","author":"SS Nosier","year":"2023","unstructured":"Nosier SS, El Nakeeb SM, Ibrahim MM, El-Gammal M, Fateen EM. Biochemical diagnosis of Sanfilippo disorder types A and B. J Genet Eng Biotechnol. 2023;21(1):112.","journal-title":"J Genet Eng Biotechnol"},{"issue":"1","key":"3971_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ejmhg.2011.08.005","volume":"9","author":"RM Shawky","year":"2008","unstructured":"Shawky RM, Zaki EA, Fateen EM, Refaat M, Eldin N. Profile of Egyptian patients with mucopolysaccharidosis. Egypt J Med Hum Genet. 2008;9(1):11\u201322.","journal-title":"Egypt J Med Hum Genet"},{"issue":"4","key":"3971_CR24","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ejmhg.2014.07.002","volume":"15","author":"EM Fateen","year":"2014","unstructured":"Fateen EM, Gouda AS, Ibrahim MM, Abdallah ZY. Fifteen years experience: Egyptian metabolic lab. Egypt J Med Hum Genet. 2014;15(4):379\u201385.","journal-title":"Egypt J Med Hum Genet"},{"key":"3971_CR25","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s12098-015-2014-x","volume":"83","author":"MA Elmonem","year":"2016","unstructured":"Elmonem MA, Mahmoud IG, Mehaney DA, Sharaf SA, Hassan SA, Orabi A, et al. Lysosomal storage disorders in Egyptian children. Indian J Pediatr. 2016;83:805\u201313.","journal-title":"Indian J Pediatr"},{"issue":"11","key":"3971_CR26","first-page":"SC05","volume":"10","author":"L Selim","year":"2016","unstructured":"Selim L, Abdelhamid N, Salama E, Elbadawy A, Gamaleldin I, Abdelmoneim M, et al. Cardiovascular abnormalities in Egyptian children with mucopolysaccharidoses. J Clin Diagn Res JCDR. 2016;10(11):SC05.","journal-title":"J Clin Diagn Res JCDR"},{"issue":"11","key":"3971_CR27","first-page":"782","volume":"87","author":"B Turkia","year":"2009","unstructured":"Turkia B, Tebib N, Azzouz H, Abdelmoula MS, Chehida B, Chemli J, et al. Incidence of mucopolysaccharidoses in Tunisia. Tunis Med. 2009;87(11):782\u20135.","journal-title":"Tunis Med"},{"issue":"2","key":"3971_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.5339\/qmj.2013.18","volume":"2013","author":"H AlObaidy","year":"2014","unstructured":"AlObaidy H. Patterns of inborn errors of metabolism: A 12 year single-center hospital-based study in Libya. Qatar Med J. 2014;2013(2):18.","journal-title":"Qatar Med J"},{"key":"3971_CR29","doi-asserted-by":"crossref","unstructured":"Fateen E, Abdallah ZY, Nazim WS, Ibrahim M, Radwan A. Mucopolysaccharidoses diagnosis in the era of enzyme replacement therapy in Egypt. Heliyon. 2021;7(8).","DOI":"10.1016\/j.heliyon.2021.e07830"},{"issue":"2","key":"3971_CR30","first-page":"62","volume":"111","author":"H Afifi","year":"2010","unstructured":"Afifi H, El-Ruby M, El-Bassyouni H, Ismail S, Aglan M, El-Harouni A, et al. The most encountered groups of genetic disorders in Giza governorate, Egypt. Bratisl Lek Listy. 2010;111(2):62\u20139.","journal-title":"Bratisl Lek Listy"},{"issue":"1","key":"3971_CR31","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/01.MXE.0000407744.14663.d8","volume":"1","author":"S Temtamy","year":"2012","unstructured":"Temtamy S, Aglan M. Consanguinity and genetic disorders in Egypt. Middle East J Med Genet. 2012;1(1):12\u20137.","journal-title":"Middle East J Med Genet"},{"issue":"2","key":"3971_CR32","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10545-005-5673-3","volume":"28","author":"S Tomatsu","year":"2005","unstructured":"Tomatsu S, Okamura K, Maeda H, Taketani T, Castrillon S, Gutierrez M, et al. Keratan sulphate levels in mucopolysaccharidoses and mucolipidoses. J Inherit Metab Dis. 2005;28(2):187\u2013202.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"3971_CR33","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/01.MXE.0000438178.09181.43","volume":"3","author":"EM Fateen","year":"2014","unstructured":"Fateen EM, Ibrahim MM, Gouda AS, Youssef ZA. Biochemical diagnosis of mucopolysaccharidoses over 11 years: the Egyptian experience. Middle East J Med Genet. 2014;3(1):16\u201323.","journal-title":"Middle East J Med Genet"},{"issue":"5","key":"3971_CR34","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3390\/jpm12050665","volume":"12","author":"MS Kim","year":"2022","unstructured":"Kim MS, Yang A, Noh E, seon, Kim C, Bae GY, Lim HH, et al. Natural history and molecular characteristics of Korean patients with mucopolysaccharidosis type III. J Pers Med. 2022;12(5):665.","journal-title":"J Pers Med"},{"issue":"23\u201324","key":"3971_CR35","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1016\/j.cca.2011.08.032","volume":"412","author":"S Ouesleti","year":"2011","unstructured":"Ouesleti S, Brunel V, Turkia HB, Dranguet H, Miled A, Miladi N, et al. Molecular characterization of MPS IIIA, MPS IIIB and MPS IIIC in Tunisian patients. Clin Chim Acta. 2011;412(23\u201324):2326\u201331.","journal-title":"Clin Chim Acta"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03971-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03971-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03971-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T13:55:26Z","timestamp":1757426126000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03971-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3971"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03971-2","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,25]]},"assertion":[{"value":"14 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Medical Research Ethics Committee at the National Research Centre, Egypt has approved the present study and the informed consent. The name of the Approval Committee that approved the study: \u201cThe Medical Research Ethics Committee\u201d. Written informed consent was obtained from the parents of the patients according to the guidelines of \u201cThe Medical Research Ethics Committee\u201d at the National Research Centre (NRC) (approval no. 044101223).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"Participants or legal guardians have consented for the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared that no conflict of interest exists.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"454"}}